{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:32:56Z","timestamp":1773739976969,"version":"3.50.1"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvoice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Voice"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jvoice.2019.11.013","type":"journal-article","created":{"date-parts":[[2020,1,2]],"date-time":"2020-01-02T08:17:04Z","timestamp":1577953024000},"page":"455-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Effects of Particle Size of Inhaled Corticosteroid on the Voice"],"prefix":"10.1016","volume":"35","author":[{"given":"Dylan","family":"Vance","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ghiath","family":"Alnouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Valentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Eichorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankti","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert T.","family":"Sataloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvoice.2019.11.013_bib0001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12890-016-0348-4","article-title":"Effect of inhaled corticosteroid particle size on asthma efficacy and safety outcomes: a systematic literature review and meta-analysis","volume":"17","author":"El Baou","year":"2017","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0002","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4168\/aair.2017.9.2.116","article-title":"Asthma-related outcomes in patients initiating extrafine ciclesonide or fine-particle inhaled corticosteroids","volume":"9","author":"Postma","year":"2017","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0003","first-page":"21","article-title":"A novel aerodynamic sizing method for pharmaceutical aerosols using image-based analysis of settling velocities","volume":"11","author":"Fishler","year":"2017","journal-title":"Inhalation"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0004","doi-asserted-by":"crossref","first-page":"52","DOI":"10.2500\/aap.2013.34.3648","article-title":"Particle size and small airway effects of mometasone furoate delivered by dry powder inhaler","volume":"34","author":"Berger","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/MCP.0000000000000115","article-title":"Small-airway disease in asthma: pharmacological considerations","volume":"21","author":"Usmani","year":"2015","journal-title":"Curr Opin Pulm Med."},{"key":"10.1016\/j.jvoice.2019.11.013_bib0006","doi-asserted-by":"crossref","DOI":"10.1208\/pt040454","article-title":"Aerodynamic particle size analysis of aerosols from pressurized metered-dose inhalers: comparison of Andersen 8-stage cascade impactor, next generation pharmaceutical impactor, and model 3321 aerodynamic particle sizer aerosol spectrometer","volume":"4","author":"Mitchell","year":"2003","journal-title":"AAPS Pharm Sci Tech"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0007","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0149-2918(03)80108-X","article-title":"Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma","volume":"25","author":"Corren","year":"2003","journal-title":"Clin Therapeut"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0008","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5606\/kbbihtisas.2016.79740","article-title":"Voice evaluation in asthma patients using inhaled corticosteroids","volume":"26","author":"Hassen","year":"2016","journal-title":"Kulak Burun Bogaz Ihtis Derg"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0009","doi-asserted-by":"crossref","DOI":"10.1183\/09031936.95.08040590","article-title":"Frequency of voice problems and cough in patients using pressurized aerosol inhaled steroid preparations","author":"Williamson","year":"1995","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.2500\/aap2007.28.3049","article-title":"Gender and age risks for hoarseness and dysphonia with use of a dry powder fluticasone propionate inhaler in asthma","volume":"28","author":"Ishizuka","year":"2007","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0011","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1378\/chest.126.1.213","article-title":"The local side effects of inhaled corticosteroids: current understanding and review of the literature","volume":"126","author":"Roland","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0012","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/MOO.0000000000000153","article-title":"Dysphonia associated with the use of inhaled corticosteroids","volume":"23","author":"Chmielewska","year":"2015","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0013","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1097\/00005537-200409000-00012","article-title":"Laryngeal findings in users of combination corticosteroid and bronchodilator therapy","volume":"114","author":"Mirza","year":"2004","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0014","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00228-005-0910-0","article-title":"Lower oropharyngeal deposition of inhaled ciclesonide via hydrofluoroalkane metered-dose inhaler compared with budesonide via chlorofluorocarbon metered-dose inhaler in healthy subjects","volume":"61","author":"Nave","year":"2005","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0015","doi-asserted-by":"crossref","DOI":"10.1097\/MOO.0000000000000580","article-title":"Medications and the larynx","author":"Harounian","year":"2019","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0016","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1081\/JAS-200057888","article-title":"Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma","volume":"42","author":"Thongngarm","year":"2005","journal-title":"J Asthma"},{"key":"10.1016\/j.jvoice.2019.11.013_bib0017","unstructured":"National Research Council (US) Subcommittee on Acute Exposure Guideline Levels. 1,1,1,2-Tetrafluoroethane (HFC-134a): acute exposure guideline levels - acute exposure guideline levels for selected airborne chemicals - NCBI bookshelf. 2002."}],"container-title":["Journal of Voice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199719303984?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0892199719303984?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:36:02Z","timestamp":1760211362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0892199719303984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0892199719303984"],"URL":"https:\/\/doi.org\/10.1016\/j.jvoice.2019.11.013","relation":{},"ISSN":["0892-1997"],"issn-type":[{"value":"0892-1997","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of Particle Size of Inhaled Corticosteroid on the Voice","name":"articletitle","label":"Article Title"},{"value":"Journal of Voice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvoice.2019.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Voice Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}